Cargando…
Proenkephalin a 119–159 (penKid) – a novel biomarker for acute kidney injury in sepsis: an observational study
BACKGROUND: Sepsis is a leading cause of death worldwide and a major challenge for physicians to predict and manage. Proenkephalin A 119–159 (penKid) is a reliable surrogate marker for the more unstable endogenous opioid peptide enkephalin, which has previously been shown to predict both acute and c...
Autores principales: | Rosenqvist, Mari, Bronton, Kevin, Hartmann, Oliver, Bergmann, Andreas, Struck, Joachim, Melander, Olle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883703/ https://www.ncbi.nlm.nih.gov/pubmed/31779591 http://dx.doi.org/10.1186/s12873-019-0283-9 |
Ejemplares similares
-
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study
por: Hollinger, Alexa, et al.
Publicado: (2018) -
Hollinger A, Wittebole X, François B, et al. Proenkephalin A 119-159 (Penkid) is an early biomarker of septic acute kidney injury: the Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int Rep. 2018;3:1424–1433
Publicado: (2018) -
Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
por: Molvin, John, et al.
Publicado: (2019) -
Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure
por: Arfsten, Henrike, et al.
Publicado: (2021) -
Proenkephalin A 119–159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial
por: von Groote, Thilo, et al.
Publicado: (2022)